Search

everythinglearnresearchcommunity

for

Search:↓

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

New compounds may help treat heart disease by activating specific potassium channels.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Three compounds from Dadap leaves may help treat hair loss.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

A new compound effectively inhibits human 5α-reductase 1.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

A new compound shows promise as a topical treatment for hair loss.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.